omega-n-methylarginine has been researched along with aliskiren in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (aliskiren) | Trials (aliskiren) | Recent Studies (post-2010) (aliskiren) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 978 | 211 | 611 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | aliskiren (IC50) |
---|---|---|---|
Renin | Homo sapiens (human) | 0.001 | |
Renin-1 | Mus musculus (house mouse) | 0.0045 | |
Renin | Rattus norvegicus (Norway rat) | 0.084 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0004 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 0.0023 | |
Renin | Macaca mulatta (Rhesus monkey) | 0.0012 | |
Renin | Oryctolagus cuniculus (rabbit) | 0.011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernini, G; Bruno, RM; Cartoni, G; Duranti, E; Ghiadoni, L; Lorenzini, G; Qasem, AA; Taddei, S; Virdis, A | 1 |
1 trial(s) available for omega-n-methylarginine and aliskiren
Article | Year |
---|---|
Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients.
Topics: Adult; Amides; Antihypertensive Agents; Arterioles; Blood Flow Velocity; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Fumarates; Humans; Hypertension; Male; Middle Aged; omega-N-Methylarginine; Ramipril; Vascular Resistance; Vascular Stiffness; Vasodilator Agents | 2012 |